NextCure, Inc.
Customers
1
1 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Dec 31, 2025
10-K filed 2026-03-05
Customers 1
Companies NXTC discloses as major customers, as a share of NXTC revenue. 1 active, 0 lapsed.
| Company | % of NXTC revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Simcere Zaiming, Inc. Non-SEC Simcere Zaiming, Inc. |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-03-05 |
In connection with the License Agreement, the Company also entered into a Subscription Agreement (the “Subscription Agreement”) pursuant to which the Company issued and sold to Simcere Zaiming, Inc. (“Simcere Zaiming”), a Delaware corporation and an affiliate of Zaiming, in a private placement, an aggregate of 338,636 shares (the “Shares”) of the common stock of the Company, par value $0.001 per share, at a price of approximately $5.904 per Share for an aggregate purchase price of $2.0 million. | ||||||
Alerts are coming
Get an email when NXTC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.